PharmaTimes International Clinical Researcher of the Year – one of the most important dates in the clinical research calendar – will take place on 17 May at the Millennium Gloucester Hotel in the heart of London’s Kensington.
News
Amryt in-licenses novel gene therapy platform from UCD
UK biotech Amryt has secured itself access to a novel gene therapy platform that could give rise to a new treatment option for patients with Epidermolysis bullosa (EB), a group of rare inherited skin disorders that cause the skin to become very fragile.
Alexion gears up to file new blood disorder drug
Alexion is gearing up to file its experimental therapy for paroxysmal nocturnal hemoglobinuria (PNH) with regulators on both sides of the Altantic following the success of a late-stage clinical trial.
NICE endorses Keytruda for bladder cancer
MSD’s Keytruda is the first and only immunotherapy to be recommended for NHS use to treat urothelial carcinoma patients, when prior platinum-containing chemotherapy fails.
Researchers call for investigation into rising mortality rates
Researchers are calling for a government investigation into the “substantial increase” in mortality seen in early 2018 in England and Wales.
New guidelines recommend hysteroscopy test for heavy periods
More women in England and Wales are to be offered a test to better determine the causes of heavy menstrual bleeding, on updated guidelines from the National Institute for Health and Care Excellence.
Patients on diabetes scheme shed weight of 15 double cheeseburgers
According to NHS England more than half of patients routinely attending sessions offered as part of its diabetes prevention programme have achieved weight losss equivalent to nearly 15 double cheeseburgers.
Charities link with BenevolentAI to discover new AMD therapies
BenevolentAI has teamed up with Action Against AMD* to find treatments and a potential cure for age-related macular degeneration, the leading cause of blindness in the UK.
Chancellor criticised for lack of action on NHS
Chancellor Philip Hammond boosted growth projections and forecast falling inflation for the UK in his Spring Statement, but health care leaders lamented his lack of action on addressing the NHS crisis.
RCGP calls for longer consultations on multimorbidity burden
GP leaders are reiterating their call for longer consultation times on the back of a new analysis showing that patients with multi-morbidities account for more than half of appointments.
Cancer Researck UK links with Ideaya on PARG inhibitors
Cancer Research UK is partnering with US biotech Ideaya Biosciences to develop small molecule inhibitors of Poly(ADP-ribose) glycohydrolase (PARG).
Speedy US review for MSD’s Keytruda in cervical cancer
US regulators will undertake a priority review of MSD’s Keytruda as a treatment for patients with advanced cervical cancer.
AbbVie, Neurocrine’s fibroid drug hits PhIII targets
A second late-stage study assessing AbbVie and Neurocrine’s experimental drug elagolix in women with uterine fibroids has met its primary endpoint.
Researchers discover ‘new line of attack’ on triple negative breast cancer
Scientists have uncovered a novel approach to fighting hard-to-treat breast cancers, triggering a new drug programme designed to develop novel targeted therapies for the disease.
Cancer drug study placed on hold after patient death
US regulators have placed on hold a clinical trial testing a combination of Advaxis’ axalimogene filolisbac and AstraZeneca’s Imfinzi after a patient died from respiratory failure.
